Skip to content
DE

Supplements for brain health and memory: what the research shows

Clinical review pending

DHA, citicoline, phosphatidylserine, lion's mane, and B vitamins: what mechanisms and clinical trials tell us about memory, amounts, and limits.

Loose gray shapes enter a clear prism and become three blue light bands.

Memory concerns make the promise of a “brain supplement” appealing. The useful question is more specific: is there a nutrient deficiency or an underlying condition, and has the supplement helped people in that situation? Correcting inadequate nutrition and improving performance beyond an already healthy baseline are different goals. The ingredients discussed here have very different research histories. None has been shown to provide general protection against dementia, but several have findings worth understanding in the populations actually studied.

What supplements may do in the brain

Some substances supply components of cell membranes, building blocks for neurotransmitters, or molecules involved in energy metabolism. DHA, phosphatidylserine, and citicoline are among the frequently studied candidates. Research on lion’s mane focuses partly on nerve growth factors, while B-vitamin research considers nutritional status and homocysteine metabolism. These mechanisms help explain why a substance might be useful. Human studies are still needed to establish whether taking more improves how someone thinks, remembers, or functions.

Omega-3 fatty acids: DHA and EPA

DHA is an important component of neuronal membranes. It is often described as accounting for around 40% of the brain’s polyunsaturated fatty acids; that does not mean 40% of the whole brain, and the proportion varies across tissues and lipid fractions. Membrane composition influences flexibility, signaling, and processes involved in nerve-cell survival. The body converts precursor fatty acids into DHA only to a limited extent. A review of DHA and a mechanistic overview discuss these functions.

EPA is more closely associated with pathways that regulate inflammation, including resolvin formation and changes in eicosanoid metabolism. Those actions should not simply be called a direct antioxidant effect. Trials use different proportions of DHA and EPA; a DHA-heavy formula is not automatically the formula with the greatest memory benefit.

Hericium erinaceus: lion’s mane

Lion’s mane mushroom contains compounds called hericenones and erinacines. Laboratory and animal studies examine whether they affect nerve growth factor, or NGF, which matters for certain nerve cells. That work does not establish how much active compound reaches the human brain after a capsule. The preclinical literature offers a research rationale, rather than proof that supplements grow new neurons in people.

Phosphatidylserine

Phosphatidylserine is a membrane phospholipid involved in communication between cells. Researchers have explored links with the release of neurotransmitters such as acetylcholine and dopamine. Older trials used material derived from bovine brain; contemporary products usually use plant sources, partly because of historical concerns about bovine spongiform encephalopathy, or BSE.

The trial results are mixed. In a six-month study of 78 people, test scores improved in all groups, including placebo. Participants with lower scores at the start showed a signal in delayed verbal recall, but improvement within a subgroup is not the same as a clear overall advantage over placebo. A separate 12-week trial involving 120 people found no significant treatment advantage for age-associated memory complaints. The study with the subgroup signal and the trial without a significant benefit support continued investigation without a blanket promise. Direct comparisons between current plant-derived products and older animal-derived preparations are limited.

Citicoline: CDP-choline

Citicoline supplies components used in choline and cytidine metabolism. They can contribute to phosphatidylcholine and the neurotransmitter acetylcholine. A small magnetic resonance spectroscopy study reported a 14% increase in the beta-nucleoside triphosphate signal, largely reflecting ATP, in the anterior cingulate cortex after six weeks. This is an imaging measure of metabolism, not a 14% improvement in memory.

How these substances relate to different brain systems

Neuronal structure and membrane function

DHA and phosphatidylserine are parts of cell membranes. Their distribution can influence how receptors and signaling proteins work. Changes in membrane composition with aging or inadequate nutrition are therefore a useful research question. They do not establish that every supplement “repairs” membranes or improves processing speed. Starting nutritional status, illness, and the amount actually absorbed all matter.

Neurotransmitter systems

Acetylcholine contributes to attention and memory formation. Its synthesis, release, transport, and receptors change with age, as described in the review of the cholinergic system. Citicoline provides building blocks; phosphatidylserine may influence membrane function and transmitter release. Two ingredients acting at different points in a pathway provide a hypothesis for a combination, not evidence that the combination works better.

Neuroplasticity and nerve growth

In mouse models, lion’s mane affected experimentally induced memory problems and processes related to NGF. Human studies are much smaller and usually measure cognitive-test performance or subjective stress. Animal findings, changes in a growth factor, and a noticeable improvement in daily life answer different questions. Each can be informative without standing in for the others.

What clinical studies show

Omega-3 fatty acids

Reviews suggest possible benefits in some older people with mild cognitive impairment. Results in cognitively healthy adults are less consistent. An 18-month randomized trial did not find a significant overall protective effect against age-related cognitive decline, although analyses involving APOE status differed. The broader meta-analysis and the review focused on mild cognitive impairment should therefore be read with their populations in mind, rather than combined into a single recommendation for everyone.

Hericium erinaceus

A 2023 pilot trial studied 1.8 g daily in 41 healthy adults aged 18–45. Participants performed the Stroop task faster 60 minutes after a single dose, while the trend toward lower subjective stress after 28 days had a p-value of 0.051. That stress result did not meet the conventional 0.05 threshold. The researchers also reported null and some negative findings. A 2019 trial analyzed 31 adults over 50 who took 3.2 g of the studied mushroom preparation daily for 12 weeks. Improvement was detected on the Mini-Mental State Examination, or MMSE, but not on the other two cognitive tests. Small samples, possible practice effects, and differing preparations make these encouraging signals preliminary.

Phosphatidylserine

A 12-month combination trial involving 190 older adults with mild cognitive impairment reported benefits in short-term memory and arithmetic. The product also contained alpha-linolenic acid, ginkgo flavonoids, and B vitamins. The study cannot determine how much phosphatidylserine contributed on its own. Older trials of animal-derived phosphatidylserine are also not automatically applicable to every current product.

Citicoline

A 2021 placebo-controlled trial enrolled 100 adults aged 50–85 who were otherwise healthy but had age-associated memory impairment. They took 500 mg daily for 12 weeks. Episodic memory and a composite memory score improved more with citicoline than placebo; both were secondary outcomes. The findings are a reason for interest in that population, rather than proof of a reliable benefit in young people whose memory is already normal. Earlier magnetic resonance spectroscopy research found age-related differences in free-choline signals. A lower signal may reflect a different distribution of choline and does not automatically indicate a deficiency.

B vitamins: B6, folate, and B12

The VITACOG trial studied older people with mild cognitive impairment. Daily treatment with 0.8 mg folic acid, 0.5 mg B12, and 20 mg B6 slowed brain atrophy, particularly among participants with higher homocysteine. A structural imaging result is meaningful, but it does not by itself establish that dementia was prevented.

A 2025 meta-analysis included 17 randomized trials and 5,275 older participants. The initial pooled result suggested a small-to-moderate benefit, with very large differences between studies and very low certainty. Removing statistical outliers and single-blind studies left a very small benefit in global cognitive function: Hedges’ g of 0.110, with a 95% confidence interval of 0.034–0.186. The authors rated that narrower finding as high-certainty evidence. This supports a modest positive effect, not a large or assured improvement in any individual’s memory. Treating a deficiency also has a different rationale from taking high doses to enhance normal performance.

Ginkgo biloba

A meta-analysis of seven trials reported benefits in people with substantial cognitive impairment. Other evidence includes a Cochrane review with inconsistent findings and a meta-analysis finding no cognitive advantage in healthy people. These populations and preparations should not be treated as interchangeable. The results do not establish a dependable attention or memory benefit for healthy adults.

Amounts, timing, and formulations

The amounts below describe research protocols, not a personal prescription. A similar number on a label does not guarantee the same composition, absorption, or clinical effect.

Omega-3

Trials have used around 1–2 g of combined EPA and DHA daily over several months. Taking them with a meal can support absorption; meal fat and formulation, such as triglyceride or ethyl ester, may make a difference. Better absorption alone does not prove a larger cognitive benefit. A study lasting three to six months is an observation period, not a promise that an effect will appear by then.

Lion’s mane

The trials described above used 1.8 g daily and 3.2 g daily of their respective preparations. A generic range such as 500 mg to 3 g of “extract” cannot capture those differences: mushroom powder, fruiting-body preparations, and concentrated extracts are not equivalent products. Compare the mushroom part used, standardization, and active-compound content as well as the weight. An effect after one dose also does not establish lasting benefit with continued use.

Phosphatidylserine

A total of 300 mg daily has often been studied, sometimes divided into three doses, for at least 12 weeks. The 120-person trial also tested 600 mg daily without finding a significant advantage. Tolerability and composition matter more than assuming every plant-derived formula is clinically interchangeable with historical bovine-brain preparations.

Citicoline

Amounts of 250–500 mg daily are commonly discussed, with study periods around 12 weeks; the 2021 memory trial used 500 mg. Citicoline is water-soluble, and a brand name is not by itself proof of quality. The names CDP-choline and citicoline help identify the actual ingredient, as distinct from a broadly labeled “choline complex.”

B vitamins

The VITACOG amounts are not a risk-free long-term regimen for self-treatment. Excessive B6 intake over time can damage nerves. Folic acid can correct blood abnormalities while leaving an underlying B12 deficiency and its neurological consequences unaddressed. Claims that methylated forms are superior for everyone, or for every MTHFR variant, go beyond the evidence discussed here. When a deficiency is present, the aim is appropriate treatment with a way to assess the response.

Why people respond differently

A supplement may close a nutritional gap yet offer little additional benefit when intake is already adequate. Age, initial cognitive status, diet, digestion, and medication all affect interpretation. Genetic variants such as APOE and MTHFR are relevant research factors, but they do not reliably select a product for an individual on their own.

Quality and composition also determine how well study findings transfer to a product. A trial of a standardized extract does not answer every question about an unrelated blend. Equally, one normal laboratory value cannot prove that an ingredient could never help. The more vague the goal and the less clear the starting problem, the harder it becomes to judge whether anything useful has changed.

Turning research into a useful personal approach

New or worsening memory problems deserve an assessment of their possible causes. Sleep, emotional strain, medication, and other health conditions may contribute. Depending on the circumstances, B12, folate, or homocysteine testing can be useful; a B12 result may need further interpretation. The omega-3 index measures EPA and DHA in red blood cells, while high-sensitivity CRP reflects nonspecific systemic inflammation. Neither directly measures memory or establishes a need for supplements.

An extensive laboratory package is therefore not a prerequisite for every nutrition decision. Start with a concrete question: what problem is being addressed, which test could change the plan, and how would improvement be recognized? Starting several products at once makes changes difficult to attribute. Before combining them, check possible interactions and the total amounts supplied across products.

Frequently asked questions

Which supplement helps memory the most?

There is no overall winner. Omega-3s, citicoline, and phosphatidylserine have shown signals in particular older or cognitively impaired groups. Treating an established nutrient deficiency has a different justification from trying to enhance performance when nutrition is already adequate.

Do these products work in healthy people?

A consistent, noticeable benefit has not been established for most of them. Small short-term changes on individual tests, such as those studied with lion’s mane, are worth investigating but do not demonstrate better functioning in everyday life.

When might an effect appear?

Many trials last eight to 12 weeks, and omega-3 studies sometimes last longer. Those are study durations, not guaranteed waiting periods. Lack of improvement does not automatically justify increasing the dose.

Can several supplements be combined?

Different mechanisms do not automatically make a combination more effective or safer. Medication interactions, duplicate ingredients, total intake, and cost all belong in the decision. A clearly defined goal makes it easier to avoid combinations that add little value.

Are they safe over the long term?

Several months of tolerability in a small study cannot answer every long-term safety question. Ginkgo may be problematic with medicines that reduce blood clotting. High-dose B6 and folic acid have specific risks, and long-term data for lion’s mane remain limited.

Do they prevent dementia?

General dementia prevention has not been established for any supplement discussed here. Slower brain atrophy in a selected population is not the same outcome as fewer dementia diagnoses. Physical activity, sleep, and management of cardiovascular risk remain parts of a broader approach to brain health.

What might support memory and concentration together?

Citicoline and DHA are studied in both areas, while lion’s mane has been investigated for measures including processing speed. Persistent concentration problems should still be understood before they are treated as a nutrient problem.

Is citicoline better than phosphatidylserine?

They relate to different parts of membrane and neurotransmitter metabolism. The available trials do not provide a reliable direct comparison that would make one the better choice for every person.

Sources